Kybella

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

4 competitors in Patient Satisfaction

#DrugCompanyPhaseTrials

1

Botox

VVitae Pharmaceuticals Inc., an Allergan affiliate

Approved

22

Kybella

AbbVie

Phase 3

13

Self Assembling Peptide

NNahda University

Preclinical

1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Neurofibromatosis Type 12 trials

Tolerability of Device Based Therapies for Neurofibromatosis Type 1 Cutaneous Neurofibromas

Completed·MMassachusetts General Hospital·Phase 1·NCT04730583·34 enrolled

Dosing and Tolerability of Deoxycholic Acid vs. Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Completed·MMassachusetts General Hospital·Phase 1·NCT06120036·20 enrolled

Patient Satisfaction1 trial

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Active, not recruiting·AbbVie·Phase 4·NCT06783621·130 enrolled

Fibroma1 trial

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Enrolling by invitation·MMassachusetts General Hospital·Phase 1·NCT06300502·15 enrolled

Lipoma1 trial

A Safety, Efficacy and Pharmacokinetic Evaluation Study of Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma

Recruiting·GGlonova Pharma Co., Ltd·Phase 1·NCT07237425·56 enrolled

Details

Drug Info

Related News